Shah, M H, Lorigan, P, . O’Brien, M E R, Fossella, F V, Moore, K N, Bhatia, S, Kirby, M & Woll, P J 2016, ' Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors. ', Investigational new drugs, vol. 34, no. 3, pp. 290-299 . https://doi.org/10.1007/s10637-016-0336-9 Investigational New Drugs